What happened?
Mycetoma is a chronic infection of skin and deeper tissues caused by certain soil bacteria (actinomycetes) or fungi. Lesions form painless, slowly enlarging masses that may discharge grain-like particles. If medical therapy fails, surgical removal of infected tissue — sometimes including amputation — can be required to control spread and preserve health.
Why does it matter?
Treatment differs by cause: bacterial actinomycetoma is often treated successfully with antibiotics and less frequently needs surgery, while fungal eumycetoma commonly requires prolonged antifungal treatment that may be incomplete, leading to surgical removal of diseased tissue or amputation in advanced cases.
How to interpret the evidence
Most cases occur in tropical and subtropical "mycetoma belt" regions, and delayed presentation is common because lesions are painless and progress slowly. In Malta/EU settings mycetoma is uncommon; clinicians should consider travel and exposure history. Availability of prolonged antifungal therapy and surgical expertise affects management and outcomes.
What remains uncertain?
This CDC overview does not imply new surgical guidelines or approvals. It describes recognised clinical outcomes and treatment approaches but does not provide local availability, specific surgical techniques, or dosing. Incidence estimates are uncertain; reported cases undercount true global burden.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.
This summary was prepared with AI assistance and checked automatically against the linked primary source. It has not been individually reviewed by a clinician.